National registry for heart attacks in young adults in Serbia
Official title: Clinical Characteristics and Outcomes of Patients with Premature Acute Myocardial Infarction in Serbia - a Multicenter National Study
Run by Cardiology Society of Serbia · NCT06753591 · Data updated 2026-11-12
This study looks at heart attacks in young adults under 45 in Serbia to see what causes them and how to improve treatment and prevention.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Cardiology Society of Serbia Academic / other |
| Locations | 11 sites (Belgrade and 10 other locations) |
| Status | Recruiting |
| Started | September 25, 2024 |
| Main results expected | September 25, 2026 |
| Study ends | September 25, 2026 |
| Registry record updated | December 31, 2024 |
| Trial ID | NCT06753591 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are young adults aged 45 years or younger who have been clinically diagnosed with acute myocardial infarction.
✕Probably not a fit
Patients older than 45 years will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational multicentric national study aims to better understand acute myocardial infarction (heart attack) in young adults aged 45 years or younger in Serbia. By analyzing patient characteristics, medical history, test results, and treatment outcomes, the research seeks to identify factors contributing to heart attacks in this population and improve prevention and treatment strategies. Participants will undergo routine tests during hospitalization, and specific blood samples will be collected for advanced analyses, including genetic testing. The study will also explore differences in heart attack causes and outcomes in younger individuals compared to older populations.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and treatment strategies for heart attacks in young adults.
How similar studies have gone: Other studies have shown success in understanding acute myocardial infarction in different populations, but this specific focus on young adults in Serbia is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients aged ≤ 45 years. Clinical and laboratory diagnosis of acute myocardial infarction (AMI) based on the Universal Definition of Myocardial Infarction. Voluntary participation with signed informed consent. Exclusion Criteria: Patients aged \> 45 years.
Where it's running
-
Military Medical Academy 1
Belgrade, Serbia Recruiting -
University Hospital Center Zvezdara
Belgrade, Serbia Recruiting -
University Hospital Center Bezanijska kosa
Belgrade, Serbia Recruiting -
University Hospital Center Zemun
Belgrade, Serbia Recruiting -
Military Medical Academy 2
Belgrade, Serbia Recruiting -
General Hospital Studenica
Kraljevo, Serbia Recruiting
Show 5 more locations
-
University Clinical Center Nis
Niš, Serbia Recruiting -
Institute for cardiovascular diseases Vojvodina
Novi Sad, Serbia Recruiting -
General Hospital Prokuplje
Prokuplje, Serbia Recruiting -
General Hospital Vrbas
Vrbas, Serbia Recruiting -
General Hospital Zrenjanin
Zrenjanin, Serbia Recruiting
Study contacts
- Principal investigator: Aleksandra Djokovic, MD, PhD — Cardiology Society of Serbia, Belgrade, Serbia
- Study coordinator: Aleksandra Djokovic, MD, PhD
- Email: drsaska@yahoo.com
- Phone: +381641404922
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Early Triple Lipid-Lowering Therapy After ACS
This trial tests whether adding bempedoic acid to high-intensity statin and ezetimibe within 72 hours after PCI helps more adults with acute coronary syndrome reach LDL-C goals than the standard two-drug approach.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Early single antiplatelet therapy after IVUS-guided PCI in ACS
This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.
-
Local and systemic macrophage activation in coronary and peripheral artery disease
This study tests whether macrophage activity inside coronary and peripheral arteries relates to circulating monocyte subtypes in people with stable and acute artery disease.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.